Medical Advisory Board

Medical Advisory Board

The Medical Advisory Board consists of four independent key opinion leaders (KOLs), who will act as key advisors to the Annexin team in advancing the clinical development of the drug candidate ANXV in the major retinal vascular diseases retinal vein occlusion (RVO) and diabetic retinopathy (DR).

Medical Advisory Board

The Medical Advisory Board was appointed during 2025 as part of the preparation work for an upcoming Phase 2b study in patients with newly diagnosed RVO, and the broadening of the indications for ANXV to include DR. The aim is to strengthen the company with the experienced team of key opinion leaders (KOL) with deep understanding and broad experience in clinical drug development and treating patients with retinal diseases. The experts will contribute to the strategic planning for a future product registration, guide preparations for the regulatory submissions including study protocols, and support effective interactions with potential strategic partners as well as with the regulatory authorities.

Dr. David S. Boyer

David S. Boyer, MD is a Senior Partner at Retina-Vitreous Associates Medical Group and Adjunct Clinical Professor of Ophthalmology at the University of Southern California/Keck School of Medicine, CA, USA. Dr. Boyer is specializing in the treatment of diseases of the retina and vitreous, and a leading clinical researcher and investigator for new treatments in macular degeneration and diabetic macular edema. He serves as an advisor for multiple research, educational and charitable institutions.

Dr. Dilsher S. Dhoot

Dilsher S. Dhoot, MD, FASRS, is a board-certified ophthalmologist. Dr. Dhoot has significant experience in clinical research, serving as primary or sub-investigator in over 100 clinical trials. Dr. Dhoot also advises pharmaceutical companies on trial design and safety and has served on data and safety monitoring committees. Dr. Dhoot has received several awards during his career including the Senior Honor Award from the American Society of Retina Specialists and the Achievement Award from the American Academy of Ophthalmology.

Dr. Arshad M. Khanani

Arshad M. Khanani, MD, MA, FASRS is a Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates and Clinical Professor at the University of Nevada, Reno School of Medicine, NV, USA. Dr. Khanani has been recognized among the top 10 researchers globally on The Ophthalmologist Power List 2025 and has received numerous prestigious awards, including the Macula Society’s Lawrence J. Singerman Medal in 2025 and the American Society of Retina Specialists Presidential Award. In 2021, Dr. Khanani founded the Clinical Trials at the Summit meeting to foster discussion on clinical trial design and data.

Dr. Michael Singer

Michael Singer, MD is a Clinical Professor of Ophthalmology at the University of Texas Health Science Center and Director of Clinical Research at Medical Center Ophthalmology in San Antonio, Texas, USA. Dr. Singer is the recipient of many awards, including the American Society of Retina Specialists Honor and Senior Honor award, the Achievement award of the American Academy of Ophthalmology, The Gary Thomas Award, Faculty of the Year of the F1000 Foundation, OSN 150 Top Retina Specialists, and Two ASRS Rhet Buckler Awards. Dr. Singer has been involved in well over 250 clinical trials. In 2018 he was inducted into the Retina Hall of Fame.